THERAVECTYS

TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs... Theravectys - We support patients and healthcare providers by developing prophylactic and therapeutic immunotherapies. Immunize-Treat-Cure... At TheraVectys, we will launch a series of clinical trials, directly or via collaboration. We strive to be a game changer in Immunotherapy and demonstrate our platform efficacy through a phase I/IIa assay of our Lenti-Covid nasal instillation vaccine.

Also known as: THERAVECTYS Inc., TheraVectys SA

Primary location: Paris France